XML 55 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The domestic and foreign components of income (loss) before provision for income taxes consisted of the following (in thousands):
Fiscal Year Ended December 31,
202420232022
Domestic
$(88,789)$(110,640)$(155,528)
Foreign
7,851 6,999 3,939 
Total net loss before taxes
$(80,938)$(103,641)$(151,589)
Schedule of Components of Income Tax Expense (Benefit)
The provision for income taxes consisted of the following (in thousands):
Fiscal Year Ended December 31,
202420232022
Current
Federal
$— $— $— 
State
512 324 45 
Foreign
3,912 3,494 2,241 
Total current income tax expense
4,424 3,818 2,286 
Deferred:
Federal
— — — 
State
— — — 
Foreign
(74)(165)— 
Total deferred income tax benefit
(74)(165)— 
Total provision for income taxes
$4,350 $3,653 $2,286 
Schedule of Effective Income Tax Rate Reconciliation
The reconciliation between the statutory federal income tax rate and the Company’s effective tax rate as a percentage of loss before income taxes is as follows:
Fiscal Year Ended December 31,
202420232022
Federal tax expense
21.00 %21.00 %21.00 %
State taxes, net of federal benefit
0.49 %0.50 %1.24 %
Foreign rate differential
(0.28)%(1.40)%(0.33)%
Withholding taxes
(2.43)%(1.77)%(0.60)%
Nondeductible compensation
(6.18)%(10.20)%(2.52)%
Stock-based compensation
(9.48)%(1.84)%(3.18)%
Change in valuation allowance
(16.40)%(18.33)%(21.41)%
Research and development credits
7.57 %7.94 %4.69 %
Nontaxable dividends
— %1.31 %— %
Other
0.34 %(0.73)%(0.40)%
Effective tax rate
(5.37)%(3.52)%(1.51)%
Schedule of Deferred Tax Assets and Liabilities
Significant components of the net deferred tax assets (liabilities) for the fiscal years ended December 31, 2024 and 2023, consisted of the following (in thousands):
December 31,December 31,
20242023
Deferred tax assets:
Accruals and reserves
$3,852 $4,409 
Deferred revenue
64,179 62,000 
Net operating loss
21,983 36,508 
Research and development tax credits
34,772 28,645 
Stock-based compensation expense
4,005 6,242 
Indirect tax reserves
377 240 
Property and equipment, net
2,088 2,000 
Capitalized research and development costs
48,726 35,505 
Operating lease liabilities
2,152 1,460 
Other deferred tax assets3,052 564 
Gross deferred tax assets
185,186 177,573 
Valuation allowance
(165,488)(150,915)
Total deferred tax assets
19,698 26,658 
Deferred tax liabilities:
Deferred contract costs
(9,329)(16,791)
Operating lease right-of-use-assets
(2,064)(1,129)
Other deferred tax liabilities
(8,067)(8,573)
Total deferred tax liabilities
(19,460)(26,493)
Net deferred tax assets
$238 $165 
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending balance of unrecognized tax benefit is as follows (in thousands):
Fiscal Year Ended December 31,
202420232022
Gross unrecognized tax benefits at the beginning of the year
$7,232 $5,310 $3,608 
Increases related to prior year tax positions133 58 224 
Increases related to current year tax positions
1,667 1,864 1,478 
Statues of limitations expirations
— — — 
Gross unrecognized tax benefits at the end of the year
$9,032 $7,232 $5,310